Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Lex genetica.

Legal Regime for Circulation of High-Tech Medicinal Products: Experience of Interstate Integration Associations

View Full Paper
Ask AI
Bookmark
Share

Authors

ДПД. В. Пономарева

Discussion

Loading...

Member takes

Overview

Analysis reveals trends in supranational regulation of high-tech medicinal products, indicating challenges in cross-border circulation.

Key Points

  • The study identifies key trends in supranational regulation impacting high-tech drug circulation.
  • It reveals the European Union's comprehensive legal framework as a model for other integration associations.
  • The analysis highlights significant barriers affecting patient access and manufacturers' market entry for high-tech drugs.
  • Fragmentary regulation at a global level stems from varying infrastructural capabilities among states.

Cite This Study

Д. В. Пономарева (2025) studied this question.

synapsesocial.com/papers/68c1b5fe54b1d3bfb60eac75https://doi.org/10.17803/lexgen-2025-4-2-28-46
View Full Paper
Ask AI
Bookmark
Share